Circulating TSP2 levels have been associated with adverse cardiovascular outcomes in patients with heart failure (HF) with preserved and reduced ejection fraction (HFpEF and HFrEF, respectively) [3, 4]. The gene discussed is THBS2; the disease is hydrops fetalis.